Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.
Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.
HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.
Current programs to dispose of unused medicines in the home are sufficient, argued representatives of industry in appealing a provision put into place by a San Francisco-area county that would place the burden of recapturing these medicines on the manufacturer.
Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.
According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot.